Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase
Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano, et al.
International Journal of Molecular Sciences
|
September 9, 2020
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
Michela Piezzo, Stefania Cocco, Roberta Caputo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2004
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy
Fortunato Ciardiello, Roberto Bianco, Roberta Caputo, et al.
International Journal of Molecular Sciences
|
October 27, 2020
Targeting Autophagy in Breast Cancer
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
Journal of Translational Medicine
|
June 27, 2022
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
Stefania Cocco, Alessandra Leone, Maria Serena Roca, et al.
Scientific Reports
|
May 9, 2025
Multidisciplinary discussion on phenotypical characterization of metastatic breast cancer and patient pathway optimization from an expert panel across South Italian regions
Raffaele Ardito, Grazia Arpino, Roberta Caputo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2002
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)
Cataldo Bianco, Giampaolo Tortora, Roberto Bianco, et al.
Eclinicalmedicine
|
August 9, 2023
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
Andrea D'Arienzo, Annarita Verrazzo, Martina Pagliuca, et al.
Frontiers in Oncology
|
April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
Roberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
Future Oncology (London, England)
|
August 22, 2023
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
Roberta Caputo, Giuseppe Buono, Vincenzo Di Lauro, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase
Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano, et al.
International Journal of Molecular Sciences
|
September 9, 2020
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
Michela Piezzo, Stefania Cocco, Roberta Caputo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2004
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy
Fortunato Ciardiello, Roberto Bianco, Roberta Caputo, et al.
International Journal of Molecular Sciences
|
October 27, 2020
Targeting Autophagy in Breast Cancer
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
Journal of Translational Medicine
|
June 27, 2022
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
Stefania Cocco, Alessandra Leone, Maria Serena Roca, et al.
Scientific Reports
|
May 9, 2025
Multidisciplinary discussion on phenotypical characterization of metastatic breast cancer and patient pathway optimization from an expert panel across South Italian regions
Raffaele Ardito, Grazia Arpino, Roberta Caputo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2002
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)
Cataldo Bianco, Giampaolo Tortora, Roberto Bianco, et al.
Eclinicalmedicine
|
August 9, 2023
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
Andrea D'Arienzo, Annarita Verrazzo, Martina Pagliuca, et al.
Frontiers in Oncology
|
April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
Roberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
Future Oncology (London, England)
|
August 22, 2023
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
Roberta Caputo, Giuseppe Buono, Vincenzo Di Lauro, et al.
Page
of 5